Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in DSGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$13,868,293
+$6,499,903 QoQ
Shares Held
958,417
+38.4% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. DSGN ranks #165 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DSGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,868,293 958,417
2026-03-31 $7,368,390 692,518
2025-12-31 $6,374,553 679,590
2025-09-30 $5,237,965 695,613
2025-06-30 $2,675,806 794,008
2025-03-31 $2,993,417 775,497
2024-12-31 $4,699,317 761,640
2024-09-30 $4,080,998 758,550
2024-06-30 $2,371,702 707,971
2024-03-31 $2,756,108 683,898
2023-12-31 $1,756,271 662,744
2023-09-30 $1,497,939 634,720
2023-06-30 $4,012,123 636,845
2023-03-31 $3,652,456 633,008
2022-12-31 $6,186,913 603,013
2022-09-30 $9,642,574 576,709
2022-06-30 $6,091,750 435,125
2022-03-31 $5,922,931 366,745
2021-12-31 $7,524,351 351,441
2021-09-30 $3,790,490 258,032
2021-06-30 $5,027,396 252,760
2021-03-31 $1,127,230 37,700